Ascendis Pharma A/S
ASND · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Bienaime Jean Jacques: Form 4
Insider disclosure · Filed · Report period 14 Apr 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q4 2025
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001612042 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- ASND on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- Tuborg Boulevard 12, Hellerup
- Incorporated in
- Denmark
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields